United States · FDA National Drug Code directory
Citalopram Hydrobromide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-0238_e98dc453-0638-4318-9778-e9a881646d36
- Product NDC
- 71335-0238
- Form
- TABLET
- Composition / generic term
- Citalopram Hydrobromide
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20071018
- Source listing expiry
- 20261231
Source-listed ingredients
- CITALOPRAM HYDROBROMIDE — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (71335-0238-1) · 71335-0238-1
- 60 TABLET in 1 BOTTLE (71335-0238-2) · 71335-0238-2
- 90 TABLET in 1 BOTTLE (71335-0238-3) · 71335-0238-3
- 100 TABLET in 1 BOTTLE (71335-0238-4) · 71335-0238-4
- 15 TABLET in 1 BOTTLE (71335-0238-5) · 71335-0238-5
- 120 TABLET in 1 BOTTLE (71335-0238-6) · 71335-0238-6
- 7 TABLET in 1 BOTTLE (71335-0238-7) · 71335-0238-7
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →